News about "Cipla"

Orchid Pharma and Cipla to Launch Cefepime-Enmetazobactam in India

Orchid Pharma has launched its new drug, Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications.

Cipla | 29/06/2024 | By Aishwarya |  153

Cipla and Takeda to Commercialize Vonoprazan in India

Cipla has signed a non-exclusive Patent License agreement with Takeda Pharmaceutical company Ltd. for ‘Vonoprazan’ for India Market for treating acid-related illnesses among patients.

Cipla | 27/06/2024 | By Aishwarya |  269

Cipla Gets Final FDA Approval for Lanreotide Injection

Cipla Ltd. has received the final approval for its Abbreviated New Drug Application (ANDA) for Lanreotide Injection 120 mg/0.5 mL, 90 mg/0.3 mL, 60 mg/0.2 mL from the United States Food and Drug Administration (US FDA).

Cipla | 23/05/2024 | By Aishwarya |  306

Cipla Extends its Investment in Achira to Advance in PoC Diagnostic

Cipla Ltd. has signed definitive agreements for further investment of up to INR 26 crore in Optionally Convertible Preference Shares of Achira Labs Pvt. Ltd., in four tranches, subject to completion of certain milestones.

Cipla | 16/05/2024 | By Aishwarya

Torrent Pharma joins race to acquire stake of Cipla promoters

Torrent Pharma joins race to acquire stake of Cipla promoters

Cipla | 24/08/2023 | By Sudeep Soparkar |  387

Venus Remedies launches its flagship R&D drug Elores in Oman

Venus Remedies launches its flagship R&D drug Elores in Oman

Cipla | 21/08/2023 | By Sudeep Soparkar |  201

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

Cipla Issues Voluntary Nationwide Recall of Six batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) due to Container Defect

Cipla | 10/07/2023 | By Sudeep Soparkar |  458

IPA Set to Host 8th Global Pharmaceutical Quality Summit, Focusing on 'Patient Centricity - A New Manufacturing and Quality Paradigm

IPA Set to Host 8th Global Pharmaceutical Quality Summit, Focusing on 'Patient Centricity - A New Manufacturing and Quality Paradigm

Cipla | 14/06/2023 | By Sudeep Soparkar |  641

Cipla in pact with Novartis Pharma for diabetes drug Galvus

During the interim Cipla will continue to market and distribute Galvus-branded products

Cipla | 17/04/2023 | By Sudeep Soparkar |  463

Cipla offices, manufacturing units under IT lense

The company will provide any further clarification/information that may be required

Cipla | 07/02/2023 | By Sudeep Soparkar |  404